|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure显示文摘 | Malyszko J Malyszko JS Pawlak K ct al | 2008 | Adv Med Sci2008，53，1： | 1 |
| 2 | Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin显示文摘 | Malyszko J Malyszko JS Kozminski P | 2009 | Renal failure2009，31，： | 1 |
| 3 | Fluvastin therapy affects TAFI concentration in kidney transplant recipients 显示文摘 | Malyszko J Malyszko JS Mysliwiec M | 2003 | Transpl Int2003，16，1： | 1 |
| 4 | Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients显示文摘 | Malyszko J Malyszko JS Pawlak K | 2008 | Perit Dial Int2008，28，： | 1 |
| 5 | Renalase, stroke, and hypertension in hemodialyzed patients显示文摘 | Malyszko J Koc-Zorawska E Malyszko JS | 2012 | Ren Fail2012，34，6： | 1 |
| 6 | Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephritic syndrome and continuous ambulatory peritoneal dialysis显示文摘 | Malyszko J Malyszko JS Mysliwiec M | 2005 | Thrombosis Research2005，115，12： | 1 |
| 7 | Hepcidin,iron status ,and renal function in chronic renal failure,kidney transplantation,and hemodialysis显示文摘 | Malyszko J Malyszko JS Pawlak K | 2006 | Am J Hematol2006，81，11： | 1 |
| 8 | Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor显示文摘 | Hryszko T Malyszko J Malyszko JS | 2001 | Thromb Res2001，104，4： | 1 |
| 9 | Visfatin and apelin, new adipocytokines,and their relation to endothelial function in patients with chronic renal failure显示文摘 | Malyszko J Malyszko JS Pawlak K | 2008 | Adv Med Sci2008，53，1： | 1 |
| 10 | Markers of endothelial damage in patients on hemodialysis and hemodiafiltration显示文摘 | Malyszko JS Malyszko J Hryszko T | 2006 | J Nephrol2006，19，2： | 1 |
| 11 | Neutrophil gelatinase-associated lipocalin is anew and sensitive marker of kidney function inchronic kidney disease patients and renal allograftrecipients显示文摘 | Malyszko J Malyszko JS Baochorzewska-Gajewska H | 2009 | Transplant Proc2009，41，1： | 1 |
| 12 | Kidney injury molecule-1 correlate with kidney function in renal allograft recipients 显示文摘 | Malyszko J Koc-Zorawska E Malyszko JS | 2010 | Transplant Proc2010，42，10： | 1 |
| 13 | Elevated resistin is related to inflammation and residual renal function in haemodialysed patients显示文摘 | Malyszko J Malyszko JS Kozminski P | 2007 | Nephrology2007，12，3： | 1 |
| 14 | Apelin,a novel adipocy- tokine, in relation to endothelial function and inflammation in kidney allograft recipients 显示文摘 | Malyszko J Malyszko JS Pawlak K at al | 2008 | Transplant Proc2008，40，10： | 1 |
| 15 | Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients 显示文摘 | Malyszko J Malyszko JS Hryszko T | 2004 | Blood Coagul Fibrinolysis2004，15，6： | 1 |
| 16 | Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients显示文摘 | Malyszko J Malyszko JS Bachorzewska-Gajewska H | 2009 | Transplant Proc2009，41，1： | 1 |
| 17 | Visfatin, a new adipocytokine, is predominantly related to inflammation/ endothelial damage in kidney allograft recipients显示文摘 | Malyszko J Malyszko JS Mysliwiec M | 2009 | Transplant Proc2009，41，1： | 1 |
| 18 | Visfatin and endothelial function in dialyzed patients显示文摘 | Malyszko J Malyszko JS Mysliwiec M | 2010 | Nephrology (Carlton)2010，15，2： | 1 |
| 19 | Hepcidin, iron status, and renal function in chronic renal fail- kidney transplantation, and hemodialysis显示文摘 | Malyszko J Malyszko JS Paliak K | 2006 | Am J Hematol2006，81，11： | 1 |
| 20 | Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients 显示文摘 | Malyszko J Malyszko JS Hryszko T | 2006 | Transplant Proc2006，38，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员